| |
| |
|
| Insider
Information: |
Leonard Braden Michael |
| Relationship: |
|
| City: |
Zionsville |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
12 |
|
| Direct
Shares |
3,590,812 |
|
|
Indirect Shares
|
45,629,696 |
|
|
| Direct
Value |
$15,985,323 |
|
|
|
Indirect Value
|
$242,258,214 |
|
|
| Total
Shares |
49,220,508 |
|
|
| Total
Value |
$258,243,537 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
31
|
4
|
|
Stock
price went up :
|
5
|
1
|
| Stock
price went down : |
26
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 120.0%
|
2,039.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Build A Bear Workshop Inc |
BBW |
Former Director of the... |
2017-09-29 |
142,043 |
2017-09-29 |
1,281,000 |
Premium* |
|
|
Prophase Labs Inc |
PRPH |
10% Owner |
|
0 |
2017-09-29 |
627,322 |
Premium* |
|
|
Orchids Paper Products Co /de |
TIS |
10% Owner |
2019-04-03 |
128,000 |
2019-04-03 |
1,329,963 |
Premium* |
|
|
Disc Medicine, Inc |
IRON |
10% Owner |
2022-10-26 |
247,500 |
2022-10-26 |
5,000,000 |
Premium* |
|
|
Enliven Therapeutics Ord Shs |
ELVN |
10% Owner |
2023-01-04 |
230,000 |
2023-01-04 |
1,767,774 |
Premium* |
|
|
Retractable Technologies Inc |
RVP |
10% Owner |
2022-12-29 |
387,500 |
2022-12-29 |
688,575 |
Premium* |
|
|
Astrotech Corporation |
ASTC |
10% Owner |
2022-12-02 |
350,000 |
2022-12-02 |
6,612,311 |
Premium* |
|
|
Metacrine, Inc. |
MTCR |
10% Owner |
2022-12-21 |
600,000 |
2022-12-21 |
6,160,570 |
Premium* |
|
|
Satsuma Pharmaceuticals, Inc. |
STSA |
10% Owner |
2022-11-21 |
150,000 |
2022-11-21 |
6,440,000 |
Premium* |
|
|
Aclaris Therapeutics, Inc. |
ACRS |
|
|
0 |
2024-02-07 |
9,395,934 |
Premium* |
|
|
Cyteir Therapeutics, Inc. |
CYT |
|
2024-03-20 |
335,000 |
2024-03-20 |
3,654,053 |
Premium* |
|
|
Reneo Pharmaceuticals, Inc. |
RPHM |
|
2024-05-14 |
1,020,769 |
2024-05-14 |
2,672,194 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
175 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BBW |
Build A Bear Workshop Inc |
Director |
– • • |
2012-05-24 |
4 |
B |
$4.61 |
$57,650 |
I/I |
12,500 |
2,412,500 |
2.25 |
- |
|
| BBW |
Build A Bear Workshop Inc |
Director |
– • • |
2012-05-25 |
4 |
B |
$4.77 |
$23,832 |
I/I |
5,000 |
2,417,500 |
2.17 |
- |
|
| BBW |
Build A Bear Workshop Inc |
Director |
– • • |
2014-05-08 |
4 |
S |
$13.66 |
$359,736 |
I/I |
(26,335) |
2,420,501 |
0 |
- |
|
| BBW |
Build A Bear Workshop Inc |
Director |
– • • |
2012-05-31 |
4 |
B |
$4.51 |
$56,343 |
I/I |
12,500 |
2,430,000 |
2.25 |
- |
|
| BBW |
Build A Bear Workshop Inc |
Director |
– • • |
2014-05-07 |
4 |
S |
$13.65 |
$505,241 |
I/I |
(37,014) |
2,446,836 |
0 |
- |
|
| BBW |
Build A Bear Workshop Inc |
Director |
– • • |
2012-06-04 |
4 |
B |
$4.45 |
$89,054 |
I/I |
20,000 |
2,450,000 |
2.25 |
- |
|
| BBW |
Build A Bear Workshop Inc |
Director |
– • • |
2014-05-06 |
4 |
S |
$13.87 |
$508,349 |
I/I |
(36,651) |
2,483,850 |
0 |
- |
|
| BBW |
Build A Bear Workshop Inc |
Director |
– • • |
2012-06-08 |
4 |
B |
$4.34 |
$217,135 |
I/I |
50,000 |
2,500,000 |
2.25 |
- |
|
| BBW |
Build A Bear Workshop Inc |
Director |
– • • |
2013-11-15 |
4 |
S |
$10.16 |
$45,705 |
I/I |
(4,499) |
2,520,501 |
0 |
- |
|
| BBW |
Build A Bear Workshop Inc |
Director |
– • • |
2012-06-14 |
4 |
B |
$4.07 |
$88,367 |
I/I |
21,722 |
2,521,722 |
2.25 |
- |
|
| BBW |
Build A Bear Workshop Inc |
Director |
– • • |
2012-06-15 |
4 |
B |
$4.06 |
$13,309 |
I/I |
3,278 |
2,525,000 |
2.17 |
- |
|
| RPHM |
Reneo Pharmaceuticals, In... |
|
– – • |
2024-05-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,672,194 |
|
% |
|
| RPHM |
Reneo Pharmaceuticals, In... |
|
• • • |
2024-05-14 |
4 |
B |
$1.54 |
$639,578 |
I/I |
414,281 |
2,672,194 |
0.01 |
% |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2022-04-21 |
4 |
B |
$1.40 |
$772,800 |
I/I |
552,000 |
2,852,000 |
1.5 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2022-04-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,860,000 |
|
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2022-04-22 |
4 |
B |
$1.38 |
$11,040 |
I/I |
8,000 |
2,860,000 |
1.5 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2022-05-16 |
4 |
B |
$1.17 |
$17,577 |
I/I |
15,000 |
2,875,000 |
1.5 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2022-05-17 |
4 |
B |
$1.26 |
$32,836 |
I/I |
26,145 |
2,901,145 |
1.5 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2022-06-03 |
4 |
B |
$1.14 |
$34,976 |
I/I |
30,800 |
2,931,945 |
1.5 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2022-06-06 |
4 |
B |
$1.16 |
$3,051 |
I/I |
2,630 |
2,934,575 |
1.42 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2022-06-16 |
4 |
B |
$1.11 |
$92,243 |
I/I |
83,199 |
3,017,774 |
1.5 |
- |
|
| RVP |
Retractable Technologies ... |
10% Owner |
– – • |
2022-04-28 |
4 |
B |
$3.58 |
$558,902 |
I/I |
156,070 |
3,076,070 |
1.5 |
% |
|
| RVP |
Retractable Technologies ... |
10% Owner |
– – • |
2022-04-29 |
4 |
B |
$3.78 |
$455,690 |
I/I |
120,502 |
3,196,572 |
1.5 |
% |
|
| RVP |
Retractable Technologies ... |
10% Owner |
– – • |
2022-04-28 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,350,000 |
|
% |
|
| RVP |
Retractable Technologies ... |
10% Owner |
– – • |
2022-05-02 |
4 |
B |
$3.84 |
$588,627 |
I/I |
153,428 |
3,350,000 |
1.5 |
% |
|
175 Records found
|
|
Page 5 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
